Revvity to acquire Human Cell Design to advance metabolic disease models
Revvity plans to acquire Human Cell Design to advance human-relevant cell models for metabolic disease drug discovery.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.